Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,736.45 +422.12 (+0.63%) CMC Crypto 200
1,426.12 -2.45 (-0.17%)
MGNX Jul 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:54PM EDT
| Previous close | 0.4500 |
| Open | 0.5000 |
| Bid | 0.2500 |
| Ask | 0.5500 |
| Strike | 5.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.4500 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.98k |
GlobeNewswireMacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will parti
Simply Wall St.US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results
As you might know, MacroGenics, Inc. ( NASDAQ:MGNX ) last week released its latest first-quarter, and things did not...
- GuruFocus.com
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ...
Insight into Macrogenics' Financial Health and Future Clinical Prospects
© 2024 Yahoo. All rights reserved.